Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Winnergy Medical Public Company Limited (WINMED.BK) operates in the healthcare distribution sector, primarily focusing on medical devices and supplies in Thailand. The company faces challenges with declining revenue and profitability, but it maintains a competitive position through established relationships with healthcare providers and a diverse product portfolio.
WINMED generates revenue by distributing a wide range of medical devices and supplies to hospitals and clinics across Thailand. The company benefits from established contracts with healthcare providers, which provide a stable revenue base. However, its operating margins are constrained due to competitive pricing pressures and rising operational costs.
Changes in healthcare spending in Thailand
Regulatory changes affecting medical device approvals
Competitive pricing strategies from major competitors
Supply chain disruptions impacting product availability
Technological disruption in medical devices
Regulatory changes impacting product approvals
Increased competition from local and international distributors
Pricing pressure from larger competitors with economies of scale
Moderate debt levels may constrain financial flexibility
Low operating margins limit the ability to absorb financial shocks
moderate - The company's performance is somewhat tied to GDP growth and healthcare spending, as economic downturns can lead to reduced hospital budgets.
Interest rates affect the company's financing costs for inventory and operations, which can impact profitability. Higher rates may reduce consumer spending on healthcare services, indirectly affecting demand.
minimal - The company does not heavily rely on credit for operations, but tighter credit conditions could impact its ability to finance inventory.
value - Investors may find the low valuation attractive, but concerns over declining margins and revenue growth could deter growth-focused investors.
moderate - The stock has shown volatility with a 1-year return of -23.9%, indicating potential sensitivity to market conditions.
